chr19-52929387-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001202473.2(ZNF816-ZNF321P):c.218A>T(p.Glu73Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000167 in 1,613,838 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001202473.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZNF816-ZNF321P | NM_001202473.2 | c.218A>T | p.Glu73Val | missense_variant | 4/4 | ||
ZNF321P | NR_037805.1 | n.82A>T | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZNF321P | ENST00000313956.4 | n.89A>T | non_coding_transcript_exon_variant | 2/2 | 2 | ||||
ZNF321P | ENST00000550843.1 | n.11A>T | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000256 AC: 64AN: 249970Hom.: 1 AF XY: 0.000317 AC XY: 43AN XY: 135472
GnomAD4 exome AF: 0.000172 AC: 252AN: 1461620Hom.: 1 Cov.: 31 AF XY: 0.000219 AC XY: 159AN XY: 727088
GnomAD4 genome AF: 0.000118 AC: 18AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 31, 2022 | The c.218A>T (p.E73V) alteration is located in exon 4 (coding exon 3) of the ZNF816-ZNF321P gene. This alteration results from a A to T substitution at nucleotide position 218, causing the glutamic acid (E) at amino acid position 73 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at